The first clinical trial of BC-821 as a cancer therapy

Trial Profile

The first clinical trial of BC-821 as a cancer therapy

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2015

At a glance

  • Drugs BC 821 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Nov 2015 New trial record
    • 06 Nov 2015 The company is planning to initiate this trial in 2016, according to a BioCancell media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top